Information & Awareness Newsletter

February 2024

For the February edition of the Information and Awareness Newsletter, we delve into the phases of clinical trials, demystifying the rigorous process that brings potential treatments to those in need. Explore ongoing Huntington’s disease trials, such as SAGE-718, PTC518, Tominersen, and WVE-003, each aiming to make strides in improving cognitive function and slowing disease progression.

Join us in solidarity with the global Rare Disease Day initiative and stay tuned for a captivating interview that sheds light on the personal significance of this collective effort. Let’s navigate 2024 together, fostering awareness, understanding, and support. Please take your time to read through the information and as always, you are welcome to contact Huntington’s Victoria if you have any questions.